S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

NGM NGM Biopharmaceuticals Inc

1.54

0.00 (0.00%)

Jan 08 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

NGM Biopharmaceuticals (NASDAQ:NGM)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more NGM Biopharmaceuticals Charts.

NGM Biopharmaceuticals (NASDAQ:NGM)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more NGM Biopharmaceuticals Charts.

NGM Biopharmaceuticals Inc News

NGM Bio Announces Closing of Tender Offer
Friday 5 April 2024 (9 months ago) • GlobeNewswire Inc.

NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting
Tuesday 19 March 2024 (10 months ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Monday 11 March 2024 (10 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 11 March 2024 (10 months ago) • Edgar (US Regulatory)

NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results
Monday 11 March 2024 (10 months ago) • GlobeNewswire Inc.

Form SC 13E3 - Going private transaction by certain issuers
Friday 8 March 2024 (10 months ago) • Edgar (US Regulatory)

Form SC 14D9 - Solicitation, recommendation statements
Friday 8 March 2024 (10 months ago) • Edgar (US Regulatory)

Form SC14D9C - Written communication relating to third party tender offer
Monday 26 February 2024 (10 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 26 February 2024 (10 months ago) • Edgar (US Regulatory)

NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP
Monday 26 February 2024 (10 months ago) • GlobeNewswire Inc.

NGM Bio to Participate in the Cowen 44th Annual Health Care Conference
Tuesday 20 February 2024 (11 months ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (11 months ago) • Edgar (US Regulatory)

More NGM Biopharmaceuticals Inc News Articles

Asia Broadband (PK)

Health Advance (PK)

Moon Equity (PK)

KULR Technology

North Bay Resources (PK)

Accredited Solutions (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions